Antihypertensive drugs and depression.
D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000009:adverse effects*; D001627:Bethanidine / Q000009:adverse effects; D002752:Chlorthalidone / Q000009:adverse effects; D003863:Depression / Q000139:chemically induced*; D004232:Diuretics; D004359:Drug Therapy, Combination; D005221:Fatigue / Q000139:chemically induced; D005665:Furosemide / Q000009:adverse effects; D006145:Guanethidine / Q000009:adverse effects; D006801:Humans; D006852:Hydrochlorothiazide / Q000009:adverse effects; D008750:Methyldopa / Q000009:adverse effects; D008875:Middle Aged; D010634:Phenobarbital / Q000009:adverse effects; D011188:Potassium; D011719:Pyrazines / Q000009:adverse effects; D012110:Reserpine / Q000009:adverse effects; D012647:Self-Assessment; D049993:Sodium Chloride Symporter Inhibitors / Q000009:adverse effects; D013805:Theobromine / Q000009:adverse effects
D000959:Antihypertensive Agents; D004232:Diuretics; D011719:Pyrazines; D049993:Sodium Chloride Symporter Inhibitors; D006852:Hydrochlorothiazide; D008750:Methyldopa; D005665:Furosemide; D012110:Reserpine; D013805:Theobromine; D002752:Chlorthalidone; D011188:Potassium; D001627:Bethanidine; D010634:Phenobarbital; D006145:Guanethidine